Cancer diagnostics News and Research

RSS

Concord Medical first quarter total net revenues increase 14.7% to $13.3 million

Concord Medical Services Holdings Limited, the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the first quarter ended March 31, 2011.

18 May 2011

Celgene, Foundation Medicine partner for clinical cancer genomic testing platforms

Foundation Medicine, Inc., a personalized cancer diagnostics company that aims to bring comprehensive cancer genome analysis to routine clinical care, today announced a strategic collaboration with Celgene Corporation.

17 May 2011

Bonn researchers to develop new blood test for lung cancer diagnosis

A person's blood reveals whether he or she has lung cancer: this has been demonstrated by researchers at the University of Bonn. In collaboration with colleagues at the Cologne University Hospital, they are developing a blood test for smokers which could save human lives in the future, since the earlier a lung tumor is detected, the better the chances of survival are.

16 May 2011

The Leonardo da Vinci Prize competition invites project submissions

International philanthropists, prestigious Universities, Hospitals, Order of Physicians, Public Administrations support and sponsor this initiative to follow scientific procedures to identify solutions with the highest potential to reduce premature cancer death and cost.

13 May 2011

PAF, Breakaway from Cancer partner for awareness campaign

The Patient Advocate Foundation – a national non-profit organization that provides professional case management services to tens of thousands of patients every year who are unable to obtain access to care because of financial or insurance denials - is pleased to partner with Breakaway from Cancer, a national fundraising and educational initiative founded by Amgen in 2005 as a complementary component to the company's sponsorship of the Amgen Tour of California, a world-class professional cycling competition, to raise awareness of the important resources available to cancer patients including prevention, education, patient care, advocacy, financial support and survivorship.

13 May 2011

Researchers identify miRNA in blood serum of lung cancer patients

Researchers have identified characteristic patterns of molecules called microRNA in the blood of people with lung cancer that might reveal both the presence and aggressiveness of the disease, and perhaps who is at risk of developing it.

13 May 2011

Prostrate cancer patients can benefit from new MRI-ultrasound fusion

Targeted biopsy, a major advance in prostate cancer diagnostics, was detailed by a UCLA team in the current issue of Urologic Oncology. The new technology fuses MRI with real-time 3D ultrasound, providing an exacting method to obtain biopsy specimens from suspicious areas in the prostate.

12 May 2011

Reprogrammed herpes virus can improve early cancer diagnosis

Scientists have used a genetically re-engineered herpes virus that selectively hunts down and infects cancerous tumors and then delivers genetic material that prompts cancers to secrete a biomarker and reveal their presence.

12 May 2011

Boston Scientific launches Expect Endoscopic Ultrasound Aspiration Needle

Boston Scientific Corporation today announced the U.S. and international launch of its Expect™ Endoscopic Ultrasound Aspiration Needle, used for acquiring tissue samples for diagnosing and staging malignancies in organs adjacent to the gastrointestinal tract. The Expect Needle received FDA clearance and CE Mark approval earlier this year and is being marketed in the U.S., Europe and other international markets.

9 May 2011

FDA clears Affymetrix's new gene profiling reagents for use in microarray instrument system

Affymetrix, Inc. today announced that the U.S. Food and Drug Administration has cleared the addition of new gene expression reagents as accessories to its GeneChip Microarray Instrument System for in vitro diagnostic use, making Affymetrix the first in the industry to provide a comprehensive microarray-based clinical toolkit for diagnostic test development, signature discovery for companion diagnostics, and translational initiatives. Affymetrix Gene Profiling Reagents offer unparalleled convenience by simplifying assay workflow, decreasing hands-on time, and reducing quality control testing compared to research-use-only-produced products.

9 May 2011

Philips, IBA enter agreement to establish proton therapy center for patients

IBA Group, a leader in advanced cancer diagnosis and therapy technologies and Royal Philips Electronics, today announced they have entered into an agreement to create state of the art patient-centric proton therapy centers.

From Philips Healthcare 9 May 2011

Study examines cancer prevalence survival by sexual orientation in California

Gay men have a higher prevalence of cancer compared with heterosexual men, and lesbian and bisexual female cancer survivors report lower levels of health than heterosexual female cancer survivors.

9 May 2011

University of California, Irvine Medical Center introduce Journal of Adolescent and Young Adult Oncology

A new effort led by a University of California, Irvine Medical Center oncologist seeks to improve cancer survival for adolescents and young adults. Dr. Leonard S. Sender has long advocated changing the approach oncologists take when treating patients and survivors aged 15 to 39.

7 May 2011

DiagnoCure to showcase Previstage GCC Colorectal Cancer Staging Test at ASCRS meeting

DiagnoCure, Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering laboratory services, today reported that its PrevistageTM GCC Colorectal Cancer Staging Test will be featured at the annual meeting of the American Society of Colon and Rectal Surgeons to be held in Vancouver, Canada, from May 15 to 17, 2011, with 3,000 expected attendees.

6 May 2011

CanTeen launches groundbreaking cancer support system

For these young people, a parent’s cancer can cause great disruption to routines and relationships and can contribute to immense feelings of anxiety and isolation. CanTeen offers young people dealing with their parent's cancer a powerful dual support system in the form of an innovative Offspring Support Program (being launched in Melbourne on 11 May and Brisbane on 17 May, with plans to go national) and a practical FREE resource book Now What…? Dealing with your parent’s cancer, which may be the only help they receive during this difficult time.

5 May 2011

Childhood cancer survivors may face high risk of late GI complications after therapy

Patients who received therapy for cancer during childhood have an increased risk of developing gastrointestinal complications later in life, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association Institute.

5 May 2011

NCI survey: Most people do not know much about clinical trials

Most people don't know much about clinical trials, according to surveys across all races and groups. Yet many members of the Hispanic community fear and distrust doctors, hospitals, and medical research. Part of this distrust may have come from the legacy of enforced sterilizations that Latinas experienced before World War II in Puerto Rico.

2 May 2011

CSI's cancer cytogenetic testing receives COG approval

CSI Laboratories, a private national cancer diagnostics laboratory, has received approval from the Children's Oncology Group to begin analyzing pediatric cytogenetic cases. The Children's Oncology Group is the world's largest children's cancer research organization and includes more than 210 member hospitals with over 6,500 medical professionals.

26 Apr 2011

Whole-genome sequencing could soon improve cancer survival rates

Cancer survival rates could improve soon with whole-genome sequencing, according to two studies published in the April 20, 2011, issue of the Journal of the American Medical Association that describe the first clinical applications of the high-tech process in patients with cancer.

20 Apr 2011

Sialix announces blood test results for early detection and treatment of breast cancer

Sialix, Inc. a pioneer in glycobiology, today announced the results of a study it participated in with researchers at the University of California, San Diego School of Medicine that could have significant impact in the prediction, early detection and treatment of cancer in humans.

20 Apr 2011

Cancer diagnostics News and Research

Concord Medical first quarter total net revenues increase 14.7% to $13.3 million

Celgene, Foundation Medicine partner for clinical cancer genomic testing platforms

Bonn researchers to develop new blood test for lung cancer diagnosis

The Leonardo da Vinci Prize competition invites project submissions

PAF, Breakaway from Cancer partner for awareness campaign

Researchers identify miRNA in blood serum of lung cancer patients

Prostrate cancer patients can benefit from new MRI-ultrasound fusion

Reprogrammed herpes virus can improve early cancer diagnosis

Boston Scientific launches Expect Endoscopic Ultrasound Aspiration Needle

FDA clears Affymetrix's new gene profiling reagents for use in microarray instrument system

Philips, IBA enter agreement to establish proton therapy center for patients

Study examines cancer prevalence survival by sexual orientation in California

University of California, Irvine Medical Center introduce Journal of Adolescent and Young Adult Oncology

DiagnoCure to showcase Previstage GCC Colorectal Cancer Staging Test at ASCRS meeting

CanTeen launches groundbreaking cancer support system

Childhood cancer survivors may face high risk of late GI complications after therapy

NCI survey: Most people do not know much about clinical trials

CSI's cancer cytogenetic testing receives COG approval

Whole-genome sequencing could soon improve cancer survival rates

Sialix announces blood test results for early detection and treatment of breast cancer

Cancer Research - Second Edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News